oxymetazoline has been researched along with Constriction, Pathological in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, D | 1 |
| Marcells, G | 1 |
| Malek, J | 1 |
| Pratt, E | 1 |
| Sacks, R | 1 |
| Snidvongs, K | 1 |
| Harvey, R | 1 |
1 other study available for oxymetazoline and Constriction, Pathological
| Article | Year |
|---|---|
Nasal peak inspiratory flow (NPIF) as a diagnostic tool for differentiating decongestable from structural nasal obstruction.
Topics: Adult; Airway Resistance; Cohort Studies; Constriction, Pathologic; Cross-Sectional Studies; Diagnos | 2014 |